Our findings thus emphasise the increasingly important role of the multifaceted CD26/DPPIV molecule in biological processes, while the functional association between CD26/DPPIV and topoisomerase II alpha may be exploited for future treatments of selected cancers. Here, DPP4 is linked to cancer.